Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

28
Number of overlapping holdings
47.5%
% of RSPH's 59 holdings also in BMED
26.7%
% of BMED's 115 holdings also in RSPH
Overlap by Weight
Sector Drift (RSPH minus BMED)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in RSPH |
Weight in BMED |
Overlap | |
---|---|---|---|---|
ABBOTT LABORATORIES | 1.8% | 2.7% | 1.8% | |
BOSTON SCIENTIFIC CORP | 1.8% | 4.9% | 1.8% | |
INTUITIVE SURGICAL INC | 1.7% | 4.9% | 1.7% | |
GILEAD SCIENCES INC | 1.6% | 3.7% | 1.6% | |
EDWARDS LIFESCIENCES CORP | 1.9% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
RSPH Overweight Relative to BMED
CENCORA INC | 2.0% | |
MCKESSON CORP | 2.0% | |
HCA HOLDINGS INC | 1.9% | |
HUMANA INC | 1.9% | |
CARDINAL HEALTH INC | 1.9% | |
CIGNA CORPORATION | 1.9% | |
UNIVERSAL HEALTH SERVICES-B | 1.9% | |
ALIGN TECHNOLOGY INC | 1.9% | |
CENTENE CORP | 1.9% | |
CVS CAREMARK CORP | 1.9% |
RSPH Underweight Relative to BMED
ROCHE HOLDING AG-BR | -3.4% | |
ARGENX SE ADR | -3.3% | |
BOSTON SCIENTIFIC CORP | -3.1% | |
INTUITIVE SURGICAL INC | -3.1% | |
LONZA GROUP AG-REG | -2.7% | |
UCB SA | -2.2% | |
REPLIGEN CORP | -2.1% | |
GILEAD SCIENCES INC | -2.0% | |
ABBVIE INC | -1.7% | |
NEUROCRINE BIOSCIENCES INC | -1.5% |